Current Opportunities for Targeting Dysregulated Neurodevelopmental Signaling Pathways in Glioblastoma
Danijela Drakulic et al, 2022, Cells CrossRef
Chrysomycin A Inhibits the Proliferation, Migration and Invasion of U251 and U87-MG Glioblastoma Cells to Exert Its Anti-Cancer Effects
Dong-Ni Liu et al, 2022, Molecules CrossRef
null
Alexander E. Braley et al, 2022 CrossRef
Prognostic biomarker prediction for glioma induced by heavy metals and their mixtures: An in-silico study
Hai Duc Nguyen, 2022, Toxicology and Applied Pharmacology CrossRef
Transcriptome and single-cell analysis reveal the contribution of immunosuppressive microenvironment for promoting glioblastoma progression
Lulu Ni et al, 2023, Front. Immunol. CrossRef
Role of Basic Fibroblast Growth Factor in Cancer: Biological Activity, Targeted Therapies, and Prognostic Value
Alessio Ardizzone et al, 2023, Cells CrossRef
Long non-coding RNA in glioblastoma invasion: Angiogenesis and mesenchymal transition via PI3K and Wnt signalling
Dexter Hoi Long Leung, 2023, APJMBB CrossRef
Genome-wide profiling of patient-derived glioblastoma stem-like cells reveals recurrent genetic and transcriptomic signatures associated with brain tumors
Elisabetta Lazzarini et al, 2023, J Neurooncol CrossRef
Multiple therapeutic approaches of glioblastoma multiforme: From terminal to therapy
Smita Kumari et al, 2023, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
Combining Pr3+-Doped Nanoradiosensitizers and Endogenous Protoporphyrin IX for X-ray-Mediated Photodynamic Therapy of Glioblastoma Cells
Gabrielle A. Mandl et al, 2023, ACS Appl. Bio Mater. CrossRef
Conditional generation of free radicals by selective activation of alkoxyamines: towards more effective and less toxic targeting of brain tumors
Patricia Piris et al, 2023, Chem. Sci. CrossRef
IRP1 mediated ferroptosis reverses temozolomide resistance in glioblastoma via affecting LCN2/FPN1 signaling axis depended on NFKB2
Yufei Lan et al, 2023, iScience CrossRef
Translocator protein (18kDA) (TSPO) marks mesenchymal glioblastoma cell populations characterized by elevated numbers of tumor-associated macrophages
Lorraine Weidner et al, 2023, acta neuropathol commun CrossRef
Non-coding RNAs (ncRNAs) and Multidrug Resistance in Glioblastoma: Therapeutic Challenges and Opportunities
Gehad Mohammed Subaiea et al, 2023, Pathology - Research and Practice CrossRef
Results of treatment of recurrent growth and metastasis of anaplastic gliomas
S. K. Badu et al, 2023, Bulletin of Neurology, Psychiatry and Neurosurgery CrossRef
Furanocoumarins as Enhancers of Antitumor Potential of Sorafenib and LY294002 toward Human Glioma Cells In Vitro
Joanna Sumorek-Wiadro et al, 2024, IJMS CrossRef
Early investigation of a novel SI306 theranostic prodrug for glioblastoma treatment
Chiara Vagaggini et al, 2024, Drug Development Research CrossRef
Glioblastoma Therapy: Past, Present and Future
Elena Obrador et al, 2024, IJMS CrossRef
STAT3 phosphorylation inhibitor Bt354 exhibits anti‐neoplastic activity in glioblastoma multiforme cells
Yi‐Chun Chiang et al, 2024, Environmental Toxicology CrossRef
CD133 significance in glioblastoma development: in silico and in vitro study
Mahdi Abdoli Shadbad et al, 2024, Eur J Med Res CrossRef
Glioblastoma: An Update in Pathology, Molecular Mechanisms and Biomarkers
Zhong Lan et al, 2024, IJMS CrossRef
Harnessing the potential of nanoengineered siRNAs carriers for target responsive glioma therapy: Recent progress and future opportunities
Kailash Ahirwar et al, 2024, International Journal of Biological Macromolecules CrossRef
PCSK5 downregulation promotes the inhibitory effect of andrographolide on glioblastoma through regulating STAT3
Huiyuan Gong et al, 2024, Mol Cell Biochem CrossRef
Identification of Novel Molecular and Clinical Biomarkers of Survival in Glioblastoma Multiforme Patients: A Study Based on The Cancer Genome Atlas Data
Luísa Esteves et al, 2024, BioMed Research International CrossRef